Skip to Content
Merck
CN

Novel syntheses of cis and trans isomers of combretastatin A-4.

The Journal of organic chemistry (2001-11-28)
K Gaukroger, J A Hadfield, L A Hepworth, N J Lawrence, A T McGown
ABSTRACT

A high-yielding, two-step stereoselective synthesis of the anticancer drug (Z)-combretastatin A-4 (1) has been devised. The method uses the Perkin condensation of 3,4,5-trimethoxyphenylacetic acid and 3-hydroxy-4-methoxybenzaldehyde followed by decarboxylation of the cinnamic acid intermediate using copper and quinoline. The iodine-catalyzed isomerization of the Z isomer 1 results in complete conversion to the E isomer. The Suzuki cross-coupling of an aryl boronic acid and vinyl bromide has also been successfully employed to produce both Z and E isomers of combretastatin A-4 stereoselectively. Both methods are far superior to the current five-step Wittig synthesis in which both isomers are produced nonstereoselectively.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
3-Hydroxy-4-methoxybenzaldehyde, 99%